Report Detail
Global Quetiapine Fumarate Market Insights, Forecast to 2025
- RnM2840429 |
- 30 January, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
The Quetiapine Fumarate was developed by AstraZeneca from 1992 to 1996. It was first approved by the FDA in 1997.
The product is invented and first produced in the UK by AstraZeneca. AstraZeneca is also the leader of the Quetiapine Fumarate base drugs.
The Average gross of the industry is over 40%. However, since there are new companies coming into the area, the gross is declining in the last several years.
The global Quetiapine Fumarate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Quetiapine Fumarate market based on company, product type, end user and key regions.
This report studies the global market size of Quetiapine Fumarate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Quetiapine Fumarate in these regions.
This research report categorizes the global Quetiapine Fumarate market by top players/brands, region, type and end user. This report also studies the global Quetiapine Fumarate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Market size by Product
Immediate Release Tablets
Extended Release Tablets
Market size by End User
Application I
Application II
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Quetiapine Fumarate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Quetiapine Fumarate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Quetiapine Fumarate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Quetiapine Fumarate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Quetiapine Fumarate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Quetiapine Fumarate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Quetiapine Fumarate Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Quetiapine Fumarate Market Size Growth Rate by Product
- 1.4.2 Immediate Release Tablets
- 1.4.3 Extended Release Tablets
- 1.5 Market by End User
- 1.5.1 Global Quetiapine Fumarate Market Size Growth Rate by End User
- 1.5.2 Application I
- 1.5.3 Application II
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Quetiapine Fumarate Market Size
- 2.1.1 Global Quetiapine Fumarate Revenue 2014-2025
- 2.1.2 Global Quetiapine Fumarate Sales 2014-2025
- 2.2 Quetiapine Fumarate Growth Rate by Regions
- 2.2.1 Global Quetiapine Fumarate Sales by Regions
- 2.2.2 Global Quetiapine Fumarate Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Quetiapine Fumarate Sales by Manufacturers
- 3.1.1 Quetiapine Fumarate Sales by Manufacturers
- 3.1.2 Quetiapine Fumarate Sales Market Share by Manufacturers
- 3.1.3 Global Quetiapine Fumarate Market Concentration Ratio (CR5 and HHI)
- 3.2 Quetiapine Fumarate Revenue by Manufacturers
- 3.2.1 Quetiapine Fumarate Revenue by Manufacturers (2014-2019)
- 3.2.2 Quetiapine Fumarate Revenue Share by Manufacturers (2014-2019)
- 3.3 Quetiapine Fumarate Price by Manufacturers
- 3.4 Quetiapine Fumarate Manufacturing Base Distribution, Product Types
- 3.4.1 Quetiapine Fumarate Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Quetiapine Fumarate Product Type
- 3.4.3 Date of International Manufacturers Enter into Quetiapine Fumarate Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Quetiapine Fumarate Sales by Product
- 4.2 Global Quetiapine Fumarate Revenue by Product
- 4.3 Quetiapine Fumarate Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Quetiapine Fumarate Breakdown Data by End User
6 North America
- 6.1 North America Quetiapine Fumarate by Countries
- 6.1.1 North America Quetiapine Fumarate Sales by Countries
- 6.1.2 North America Quetiapine Fumarate Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Quetiapine Fumarate by Product
- 6.3 North America Quetiapine Fumarate by End User
7 Europe
- 7.1 Europe Quetiapine Fumarate by Countries
- 7.1.1 Europe Quetiapine Fumarate Sales by Countries
- 7.1.2 Europe Quetiapine Fumarate Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Quetiapine Fumarate by Product
- 7.3 Europe Quetiapine Fumarate by End User
8 Asia Pacific
- 8.1 Asia Pacific Quetiapine Fumarate by Countries
- 8.1.1 Asia Pacific Quetiapine Fumarate Sales by Countries
- 8.1.2 Asia Pacific Quetiapine Fumarate Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Quetiapine Fumarate by Product
- 8.3 Asia Pacific Quetiapine Fumarate by End User
9 Central & South America
- 9.1 Central & South America Quetiapine Fumarate by Countries
- 9.1.1 Central & South America Quetiapine Fumarate Sales by Countries
- 9.1.2 Central & South America Quetiapine Fumarate Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Quetiapine Fumarate by Product
- 9.3 Central & South America Quetiapine Fumarate by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Quetiapine Fumarate by Countries
- 10.1.1 Middle East and Africa Quetiapine Fumarate Sales by Countries
- 10.1.2 Middle East and Africa Quetiapine Fumarate Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Quetiapine Fumarate by Product
- 10.3 Middle East and Africa Quetiapine Fumarate by End User
11 Company Profiles
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca Quetiapine Fumarate Products Offered
- 11.1.5 AstraZeneca Recent Development
- 11.2 Intas
- 11.2.1 Intas Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Intas Quetiapine Fumarate Products Offered
- 11.2.5 Intas Recent Development
- 11.3 TAPI
- 11.3.1 TAPI Company Details
- 11.3.2 Company Business Overview
- 11.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 TAPI Quetiapine Fumarate Products Offered
- 11.3.5 TAPI Recent Development
- 11.4 Accord
- 11.4.1 Accord Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Accord Quetiapine Fumarate Products Offered
- 11.4.5 Accord Recent Development
- 11.5 Hexal
- 11.5.1 Hexal Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Hexal Quetiapine Fumarate Products Offered
- 11.5.5 Hexal Recent Development
- 11.6 Dr.Reddy's
- 11.6.1 Dr.Reddy's Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Dr.Reddy's Quetiapine Fumarate Products Offered
- 11.6.5 Dr.Reddy's Recent Development
- 11.7 Lupin
- 11.7.1 Lupin Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Lupin Quetiapine Fumarate Products Offered
- 11.7.5 Lupin Recent Development
- 11.8 Sun Pharmaceutical
- 11.8.1 Sun Pharmaceutical Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Sun Pharmaceutical Quetiapine Fumarate Products Offered
- 11.8.5 Sun Pharmaceutical Recent Development
- 11.9 Hunan Dongting Pharm
- 11.9.1 Hunan Dongting Pharm Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Hunan Dongting Pharm Quetiapine Fumarate Products Offered
- 11.9.5 Hunan Dongting Pharm Recent Development
- 11.10 SuZhou NO.4 Phamaceutical Factory
- 11.10.1 SuZhou NO.4 Phamaceutical Factory Company Details
- 11.10.2 Company Business Overview
- 11.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Products Offered
- 11.10.5 SuZhou NO.4 Phamaceutical Factory Recent Development
- 11.11 Fuan Pharmaceutical
- 11.12 Zhejiang Supor Pharmaceuticals
- 11.13 Zhejiang Huahai Pharmaceutical
12 Future Forecast
- 12.1 Quetiapine Fumarate Market Forecast by Regions
- 12.1.1 Global Quetiapine Fumarate Sales Forecast by Regions 2019-2025
- 12.1.2 Global Quetiapine Fumarate Revenue Forecast by Regions 2019-2025
- 12.2 Quetiapine Fumarate Market Forecast by Product
- 12.2.1 Global Quetiapine Fumarate Sales Forecast by Product 2019-2025
- 12.2.2 Global Quetiapine Fumarate Revenue Forecast by Product 2019-2025
- 12.3 Quetiapine Fumarate Market Forecast by End User
- 12.4 North America Quetiapine Fumarate Forecast
- 12.5 Europe Quetiapine Fumarate Forecast
- 12.6 Asia Pacific Quetiapine Fumarate Forecast
- 12.7 Central & South America Quetiapine Fumarate Forecast
- 12.8 Middle East and Africa Quetiapine Fumarate Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Quetiapine Fumarate Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Quetiapine Fumarate . Industry analysis & Market Report on Quetiapine Fumarate is a syndicated market report, published as Global Quetiapine Fumarate Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Quetiapine Fumarate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
